When it comes to our health, paying attention to subtle signs can often be crucial. One such sign that often goes unnoticed ...
Imdelltra does have safety issues, with one patient in the 10mg arm of the study dying of respiratory failure, and the FDA has approved the drug with a boxed warning for cytokine release syndrome and ...
MoonLake Immunotherapeutics starts Phase 3 VELA program of the Nanobody® sonelokimab in patients with moderate-to-severe hidradenitis suppurativa ...
BERLIN, Germany I May 15, 2024 I Bayer announced today initiation of dosing in a Phase I first-in-human clinical study with 225Ac-PSMA-Trillium (BAY 3563254), ...